Results

Total Results: 1,987 records

Showing results for "harms".

161. Arthritis-Psoriatric Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_executive.pdf
     April 01, 2012 - Objectives This report summarizes the evidence on the comparative efficacy, effectiveness, and harms … KQ 3: For patients with PsA, do drug therapies differ in harms, tolerability, patient adherence, or … KQ 4: What are the comparative benefits and harms of drug therapies for PsA in subgroups of patients … Summary of findings Key Comparisons Efficacy and Effectiveness Strength of Evidence Grade Harms … Information generally was insufficient for the comparative harms, tolerability, adverse events, and

162. Living Systematic Review on Plant-Based Treatment for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-treatments-revised-protocol.pdf
     March 29, 2023 - or better benefits for pain while avoiding potential unintended consequences that could result in harms … Similarly, it is important to identify harms and adverse effects of PBCs. … In adults with chronic pain, what are the harms of cannabinoids? 3. … We do not anticipate excluding observational studies assessing harms. … Systematic reviews will be used to identify primary studies and 5 to summarize harms of

163. Autism-Update Clinician (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_clinician.pdf
     September 01, 2014 - Spectrum Disorder Key Clinical Issue What evidence is available regarding the effectiveness, benefits, and harms … many other interventions, the evidence is insufficient to permit an estimate of their benefits or harms … This does not mean that these interventions are not associated with benefits or harms but that further … other medical interventions, including serotonin- reuptake inhibitors and stimulant medications.  Harms … Note Regarding Possible Harms Other than for risperidone and aripiprazole, there was not enough evidence

164. Disposition of Comments Report for Oral Contraceptive Use for the Primary Prevention of Ovarian Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_disposition-comments.pdf
     June 07, 2013 - Overall Benefits and Harms of OCs (pg.211) Page 245. Table 59. … Overall Benefits and Harms of OCs (pg. 229) Figure 52 - Y axis is unclear. … Overall Benefits and Harms of OCs (pg. 230, table 62?) … Overall Benefits and Harms of OCs (pg. 251-253) Figure 81-84. … Overall Benefits and Harms of OCs The future research sections are clear.

165. Template for Reports Developed (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-future_research.pdf
     October 26, 2012 - Harms were not reported. … Harms were not reported. ES-2 Table A. … Harms were not reported. … Harms were not reported. 3 Table 1. … Harms were not reported.

166. Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment: Comparative Effectiveness Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cancer-anemia-update/research
     April 25, 2013 - Structured Abstract Objectives To update the 2006 systematic review of the comparative benefits and harms … The balance of benefits and harms was examined in a decision model. … important unanswered question is whether dosing practices and overall ESA exposure might influence harms

167. Executive Summary: Comparative Effectiveness Review No. 256_Effectiveness of Telehealth for Women's Preventive Services (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-256-telehealth-women-preventive-services-executive-summary.pdf
     June 01, 2022 - - efficacy, post-traumatic stress disorder, and safety behaviors (low SOE), and unclear evidence on harms … utilization. • Studies did not adequately evaluate factors related to access, health equity, or potential harms … Data on harms was extremely limited for IPV and not addressed in studies of contraceptive care. … Number of Studies;* Study Design; Participants (n) Overall Effect Strength of Evidence Harms … family planning or STI counseling or evaluated factors related to access, health equity, or potential harms

168. Noninvasive Testing for Coronary Artery Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/coronary-artery-disease-testing/research
     March 29, 2016 - Abstract Objectives This report evaluates the current state of evidence regarding effectiveness and harms … Harms were rarely reported, and limited information regarding radiation exposure was provided. … Assessment of harms was limited.

169. A Decisionmaking Tool for You and Your Health Care Professional (pdf file)
     effectivehealthcare.ahrq.gov/decision-aids/lung-cancer-screening/static/lung-cancer-screening-patient-encounter.pdf
     March 01, 2016 - Before making a decision, you should think about the possible benefits and harms of lung cancer screening … What are the possible benefits and harms of lung cancer screening? … * What are the possible benefits and harms of lung cancer screening with LDCT? … The possible benefits and harms from lung cancer screening represent the “average” effect and may not … Researchers do not know the possible benefits or harms of finding other things about your health through

170. A Decisionmaking Tool for You and Your Health Care Professional (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/lung-cancer-screening-patient-encounter.pdf
     March 01, 2016 - Before making a decision, you should think about the possible benefits and harms of lung cancer screening … What are the possible benefits and harms of lung cancer screening? … * What are the possible benefits and harms of lung cancer screening with LDCT? … The possible benefits and harms from lung cancer screening represent the “average” effect and may not … Researchers do not know the possible benefits or harms of finding other things about your health through

171. Evidence Summary for Treatments for Acute Pain: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-evidence-summary.pdf
     December 01, 2020 - Evidence did not suggest an increased risk of serious harms for any intervention, though studies were … not designed to assess serious harms. … Evidence on how benefits or harms varied in subgroups was lacking. … Additionally, trials were not designed to evaluate how benefits and harms varied in subgroups. … acute pain on non-pain outcomes; effects of therapies on long-term outcomes; and how benefits and harms

172. Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_1.pdf
     April 01, 2020 - • Efficacy and harms of prescription drug treatment for CATD: – In adults with mild to moderate … or supplements for cognition, function, and harms in CATD. … Evidence on the efficacy and harms of CATD drugs had several limitations. … Harms reporting was poor. … Studies should systematically collect data on potential harms of cognitive testing.

173. Research Protocol: Care Interventions for PeopleWith Dementia (PWD) and Their Caregivers (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pwd-care-interventions-protocol.pdf
     February 22, 2019 - While nondrug interventions are generally presumed safe, few trials have reported information on their harms … in People With Dementia (PWD) • KQ1: For people with dementia (PWD), what are the benefits and harms … • KQ7: For people with dementia (PWD), what are the benefits and harms for care interventions aimed … Societal costs, including caregiving time/time spent on activities Harms, including isolation, … for quality of life, function, or non-BPSD symptoms in PWD KQ 5-6: Evaluate benefits and harms of

174. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0264_01-14-2008.pdf
     January 01, 2008 - NSAIDs (these are rarely used alone and have no disease-modifying properties)) Outcome(s): Potential harms … For children with juvenile idiopathic arthritis, do drug therapies differ in harms, tolerability, adherence … What are the comparative benefits and harms of drug therapies for juvenile idiopathic arthritis in

175. ASSESSING THE QUALITY OF INCLUDED STUDIES (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/assessing-the-risk-of-bias_draft-report.pdf
     June 02, 2011 - (CONSORT Harms extension, 2004). 24 For a detailed explanation of terms associated with harms please … Although reviewers recognize the importance of harms outcomes, harms are generally ignored in quality … The McMaster University Harms scale (McHarm) tool was developed specifically for evaluating harms and … Was the mode of harms collection specified as ACTIVE? 6. … Did the study specify WHO collected the harms? 8.

176. Allergy-Seasonal Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_executive.pdf
     July 01, 2013 - The quality of harms reporting was assessed using the USPSTF rating, with specific attention to both … , underreporting or inconsistent reporting of harms. 6 Two reviewers independently assessed the … Efficacy Outcome Harms Outcome 1. … Agreed-upon reporting standards for effectiveness and harms outcomes are needed. … McMaster Quality Assessment Scale of Harms (McHarm) for Primary Studies.

177. Cervical Ripening in the Outpatient Setting | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cervical-ripening/protocol
     January 16, 2020 - KQ1a: How do effectiveness and harms vary by choice of prostaglandin?     … Include high quality cohort and case-control studies for harms. … Include high quality cohort and case-control studies for harms.  … Include high quality cohort and case-control studies for harms. … Include high quality cohort and case-control studies for harms.

178. For patients with insomnia, how do commonly used medications compare for effectiveness and harms, including addictive potential. | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-with-insomnia-how-do-commonly-used-medications-compare-for-effectiveness-and-harms-including-addictive-potential
     September 22, 2010 - For patients with insomnia, how do commonly used medications compare for effectiveness and harms, including … quality of life, sleep quality, fatigue Describe any health-related risks, side effects, or harms

179. Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior.pdf
     August 18, 2022 - What are the harms associated with treating children under 18 years of age for disruptive behaviors … Do interventions for disruptive behaviors vary in effectiveness and harms based on treatment history … Do interventions for disruptive behaviors vary in effectiveness and harms based on characteristics of … Adverse effects/harms: - Metabolic effects: weight gain, hyperglycemia and diabetes, hyperlipidemia … - Other harms, as reported Timing KQs 1-6. Any length of follow-up Setting KQs 1-6.

180. The Effectiveness and Risks of Long-term Opioid Treatment of Chronic Pain | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/chronic-pain-opioid-treatment/research-protocol
     December 19, 2013 - In addition, accumulating evidence indicates increasing rates of harms associated with prescription opioids … or no opioid on: 1) opioid abuse, addiction, and related outcomes; 2) overdose; and 3) other harms, … including gastrointestinal-related harms, falls, fractures, motor vehicle accidents, endocrinological … harms, infections, cardiovascular events, cognitive harms, and psychological harms (e.g., depression … , cardiovascular events, cognitive harms, and psychological harms (e.g., depression) Exclude: Intermediate